For the quarter ending 2026-03-31, BCYC made $887K in revenue. -$62,599K in net income. Net profit margin of -7057.38%.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Collaboration revenue | 887 | 47,955 | 11,734 | 2,920 |
| Research and development | 48,901 | 51,770 | 58,426 | 71,029 |
| General and administrative | 17,468 | 20,893 | 18,859 | 18,493 |
| Total operating expenses | 66,369 | 72,663 | 77,285 | 89,522 |
| Loss from operations | -65,482 | -24,708 | -65,551 | -86,602 |
| Interest and other income | 4,877 | 5,876 | 6,700 | 7,473 |
| Interest expense | 48 | 57 | 44 | 54 |
| Total other income, net | 4,829 | 5,819 | 6,656 | 7,419 |
| Net loss before income tax provision | -60,653 | -18,889 | -58,895 | -79,183 |
| Provision for (benefit from) income taxes | 172 | 1,265 | 205 | -231 |
| Net loss | -60,825 | -20,154 | -59,100 | -78,952 |
| Foreign currency translation adjustment | -1,774 | -34 | -108 | -1,902 |
| Total comprehensive loss | -62,599 | -20,188 | -59,208 | -80,854 |
| Basic EPS | -0.87 | -0.291 | -0.85 | -1.14 |
| Diluted EPS | -0.87 | -0.291 | -0.85 | -1.14 |
| Basic Average Shares | 69,683,471 | 69,366,652 | 69,303,746 | 69,252,009 |
| Diluted Average Shares | 69,683,471 | 69,366,652 | 69,303,746 | 69,252,009 |
BICYCLE THERAPEUTICS PLC (BCYC)
BICYCLE THERAPEUTICS PLC (BCYC)